There is evidence that renin-angiotensin system inhibitors suppress tumor angiogenesis by reducing vascular endothelial growth factor expression and altering the tumor microenvironment (Greene and Amaral, 2002[23]; Kubota et al., 2011[31]). This evidence concerns the gene VEGFA and neoplasm.